High Flow Nasal Cannula Therapy for Childhood OSA
Key facts
- Who runs it
- Chinese University of Hong Kong
- Where
- Hong Kong1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Completed
- People taking part
- 32 people enrolled
- Started
- 1 Jul 2019
- Ended
- 31 May 2024
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- High flow nasal cannula
- Continuous positive airway pressure
- Record updated
- 7 June 2024
Who can take part
- Age
- 6 years to 18 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
Show the full registry criteria (8)Hide the full registry criteria
Who can take part
- Diagnosis of moderate-to-severe OSA requiring CPAP therapy (Moderate-to-severe OSA is defined as an OAHI ≥ 5 events per hour and reported history of habitual snoring of 3 nights or more per week)
Who cannot take part
- Prior use of PAP or HFNC therapy
- Syndromal diseases
- Pathological central apnoea, chronic respiratory failure or neuromuscular disease as they would require bilevel PAP
- Secondary obesity e.g. Prader-Willi syndrome, Cushing's syndrome
- History of pneumothorax or pneumomediastinum
- Cranio-facial anomalies
- Refusal to use non-invasive ventilation
Where is this trial?
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
The main objective of this study is to evaluate the efficacy of high-flow nasal cannula (HFNC) therapy in children with OSA.
Read full original descriptionShow less
Children and adolescents aged 6 to 18 years old with a diagnosis of moderate-to-severe OSA requiring CPAP therapy will be recruited.
In phase 1 study, eligible subject will be recruited for HFNC therapy titration with PSG to assess treatment efficacy. After titration, if HFNC therapy is shown to be effective, the participants will be recruited into the phase 2 intervention period to evaluate the compliance and quality of life with HFNC therapy. At baseline and follow-up visits, neurobehavioural and quality of life surveys will be completed, compliance data will be obtained.
The 2 groups in the trial
- High flow nasal cannula (HFNC)Treatment being tested
High flow nasal cannula therapy
Treatment: High flow nasal cannula
- Continuous positive airway pressure (CPAP)Existing treatment, for comparison
Continuous positive airway pressure therapy
Treatment: Continuous positive airway pressure
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- High-flow Nasal Cannula as an Alternative Intervention for Children and Adolescents With Obstructive Sleep Apnoea
- Publications
- Record updated
- 7 June 2024